NYSE: SQMChemical & Mining Co Of Chile Inc Stock
$34.20-0.76 (-2.17%)
Updated Apr 30, 2025
SQM Price
$34.20
Fair Value Price
N/A
Market Cap
$9.77B
52 Week Low
$31.27
52 Week High
$50.73
P/E
14.26x
P/B
1.89x
P/S
2.29x
PEG
0.57x
Dividend Yield
0.62%
Revenue
$4.53B
Earnings
$685.12M
Gross Margin
29.3%
Operating Margin
25.73%
Profit Margin
15.1%
Debt to Equity
1.22
Operating Cash Flow
$2B
Beta
1.23
Next Earnings
May 20, 2025
Ex-Dividend
N/A
Next Dividend
N/A
SQM Overview
Sociedad Química y Minera de Chile S.A produces and distributes specialty plant nutrients (fertilizers), iodine and its derivatives, lithium and its derivatives, potassium chloride and sulfate, industrial chemicals, and other products and services. Its iodine and derivatives products are used in antiseptics, disinfectants, pharmaceutical synthesis, electronics, dye components, and to polarize film for LCDs and LEDs. The company was incorporated in 1968 and is headquartered in Santiago, Chile.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine SQM's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important SQM news, forecast changes, insider trades & much more!
SQM News
Overview
Due Diligence Score
–
Industry Average (36)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SQM scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
SQM ($34.20) is trading below its intrinsic value of $35.17, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SQM is good value based on its earnings relative to its share price (14.26x), compared to the US market average (29.18x)
P/E vs Market Valuation
SQM is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more SQM due diligence checks available for Premium users.
Valuation
SQM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
14.26x
Industry
28.11x
Market
29.18x
SQM is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SQM is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
SQM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.89x
Industry
3.2x
SQM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
SQM price to earnings growth (PEG)
For valuing profitable companies with growth potential
SQM is good value based... subscribe to Premium to read more.
PEG Value Valuation
SQM's financial health
Profit margin
Revenue
$4.5B
Net Income
$685.1M
Profit Margin
15.1%
SQM's Earnings (EBIT) of $1.17B... subscribe to Premium to read more.
Interest Coverage Financials
SQM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$11.5B
Liabilities
$6.3B
Debt to equity
1.22
SQM's short-term assets ($5.58B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SQM's short-term assets ($5.58B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SQM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SQM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$1.6B
Investing
-$1.2B
Financing
$282.4M
SQM's operating cash flow ($1.60B)... subscribe to Premium to read more.
Debt Coverage Financials
SQM vs Specialty Chemical Stocks
Chemical & Mining Co Of Chile Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.